Background: Contrast-induced nephropathy (CIN) is the third leading cause of hospital-acquired acute renal failure. Objective: The purpose of the present study was to compare the incidence and associated risk factors of contrast induced nephropathy in diabetes and non-diabetic patients. Methodology: This was cross-sectional study performed in the
Introduction
Diabetes mellitus is the most widespread affection of mankind. Diabetes is a syndrome characterized by chronic hyper-glycemia and disturbance of carbohydrate, fat and protein metabolism associated with absolute or relative deficiencies in insulin secretion and/or insulin action 1 . Contrast-induced nephropathy (CIN) is the third leading cause of hospital-acquired acute renal failure, accounting for 10.0% of all cases of hospital-acquired renal failure 2 . Two of the most important risk factors are baseline impaired renal function or estimated glomerular filtration rate (eGFR) <60 ml/min/1.73m 2 and diabetes mellitus. Contrast media volume is the most important modifiable risk factor. Diabetic patients represent a significant proportion of those undergoing contrast exposures due to high prevalence of diabetes in the general population and the ability of the disease to cause a broad spectrum of cardiovascular diseases that require radiological procedures using CM. The incidence of CIN in diabetic patients varies from 5.7 to 29.4%. Importantly, in diabetic patients with preserved renal function and the absence of other risk factors, the rate of CIN are usually comparable to those of a non diabetic population, while clinically important CIN usually occurs in a subset of diabetics with underlying renal insufficiency. In one study CIN occurred in 27% of diabetic patients with baseline serum creatinine 2.0¬ to 4.0 mg/dL and in 81.0% of those with serum creatinine >4mg/dl. In another study, CIN occurred in post percutaneous coronary intervention 15.1% of patients without chronic kidney disease vs 27.4% in those with chronic kidney disease 3 . Irrespective of cause, preexisting renal impairment appears to be the most important risk factor, patients with creatinine levels greater than 1.5 mg/dL were identified as being under a higher risk. The chance of developing CIN may be up to 7 times greater in patients with CKD 4 . Davidson et al 5 in a series of 1,144 patients undergoing cardiac catheterization, found a low risk of contrast induced nephropathy in patients with normal renal function, but a higher risk in those with preexisting azotemia (serum creatinine level >1.2 mg/dl). The risk increased exponentially with serum creatinine concentration like 20.0% incidence in those with a serum creatinine levels of 2 mg/dL (177 pmol/L) From the above discussion, it can be categorically stated that CIN may occur not only in high risk patients but also in general population. In high risk patients, it could be fatal. So these groups of patients need to be evaluated with regard to the incidence of risk factors for and outcome of CIN. Therefore this present study was undertaken to compare the incidence and associated risk factors of contrast induced nephropathy in diabetes and non-diabetic patients.
Methodology
This was a prospective, observational study was carried out in the Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Patients who underwent elective coronary angiographic evaluation at the department of cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, during the study period who fulfilled the inclusion criteria were selected. All patients 18 years and above who underwent coronary angiography with or without percutaneuous Transluminal coronary Angioplasty with normal or impaired renal function, with or without Diabetes Mellitus or hypertension were included in the study. Age below 18 years, patients with preexisting end stage renal disease requiring dialysis, history of contrast allergy, patients who developed shock after the procedure, patients underwent other contrast exposure within one week from the index procedure were excluded in this study. Patients were divided in to two groups group A (patients with diabetes mellitus) and group B (Patients without diabetes mellitus). Demographic profile, clinical examination and relevant investigation reports and procedural factors of all patients were recorded in pre-designed data collection sheet. The anti-ischaemic, anti-hypertensive, lipid lowering, platelet inhibitors, and oral hypoglycemic agents (except metformin) if taking were continued. 3, Low osmolar, non-ionic radiocontrast agent iopamidol (Lopamir 370) was used for all patients. Base line serum creatinine was estimated before procedure. Post procedure serum creatinine was estimated at 48 hours after coronary angiogram. For estimation of serum creatinine 2 samples of venous blood (one pre-procedure, 1 post-procedure) 3 cc each were collected and send immediately to laboratory. Sample analyzed by automated clinical chemistry analyzer ABX Pentra 400 of HORIBA ABX, France. Estimated GFR (eGFR) was calculated from MDRD formula both pre and 48 hour post procedure. Study population was divided into two groups. Group A-presence of diabetes mellitus and/or impaired renal function (estimated GFR<60ml/min/1.73m2, MDRD prediction equation) and group B absence of diabetes mellitus and estimated GFR ≥60ml/min/1.73m2). Incid¬ence of CIN in these groups were compared. We tried to analyze whether there is relationship between the incidence of CIN with renal impairment, diabetes mellitus, contrast volume, hypertension, Dyslipidemia left ventricular ejection fraction <40%. Statistical analysis was conducted using SPSS 23.0 for windows software. Categorical data were expressed as frequencies and corresponding percentages. Parametric data were expressed in mean±SD. Parametric data were evaluated by independent sample "t" test, categorical data were evaluated by Chi-square test as needed. A multivariable logistic regression model were applied including all the potential confounding variables. Level of significance for all analytical test were set at 0.05 and p value <0.05 is considered significant.
Results
Total of 250 patients who underwent elective coronary angiographic evaluation at the department of cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, during the study period who fulfilled the inclusion criteria were selected. Demographic and baseline characteristics of the study population. The mean age of patient in group A was 55.83±9.00 years whereas the mean age of patients in group B was 50.44±11.63 years. There were statistically significant difference between two groups (P<0.001). Out of 112 patients in group A and 138 patients in group B 87(77.7%) and 119 (86.2%) were male and 25 (22.3%) and 19 (13.8%) were female respectively. Mean (±SD) body mass index (BMI) were 23.74±2.82 and 23.17±2.19 kg/m2 of group A and group B patients, respectively. Systolic blood pressure of group A and group B patients (mean±SD) were 127.45±14.43 and 126.01±11.87 mmHg, and diastolic blood pressure was 63.13±9.35 and 83.59±9.00mmHg, respectively. Serum creatinine concentration in group A was significantly higher (P<0.001) than group B (mean±SD:107.57±25.48 and 87.01±12.88 µmol/L). In Group A 86 (76.8%) and none in Group B had diabetes mellitus. Left ventricular ejection fraction in group A and group B patients were 58.72±10.40% and 57.64±11.01%, respectively. Total volume of contrast media used was significantly higher in group A than group B patients (mean ± SD 81.03 ± 36.53ml and 59.41 ± 20.89 ml, P<0.001) ( Table 1) . Presence of risk factors in group A and group B patients. In group A and group B, impaired renal function (eGFR <60 ml/min/1.73 m2) was present in 57(50.9%) and none (0%), diabetes mellitus was present in 86(76.8%) and none (0%), hypertension in 53(47.3%) and 52(37.7%), dyslipidemia in 57(50.9%) and 3(2.2%) and history of myocardial infarction (MI) in 27(24.1%) and 17(12.3%) patients respectively. Statistically hypertension showed no significant variation between the two study groups. However, presence of other risk factors was significantly high among group A patients, impaired renal function (P<0.001, diabetes mellitus (P<0.001), dyslipidemia (P<0.001), and previous myocardial infarction (P<0.05) ( Table 2 ).
Distribution of study subjects on the basis of the procedure followed in group A and group B patients. Coronary angiogram was done in 90 (80.4%) and in 134 (97.1%), and coronary angiogram plus percutaneous transluminal coronary angioplasty in 22 (19.6%) and 4 (2.9%) patients of group A and B, respectively (P<0.001). Distribution of procedures in between groups were found statistically significant (P<0.001) ( Pre-procedure selected investigations done of the study subjects. In group A (n=112) 101 patients (90.2%) had baseline serum creatinine ≤140µmol/L. In group B (n=138), all patients had baseline serum creatinine >140µmol/L (100%). The difference in baseline creatinine serum creatinine was found statistically significant (P<0.001). In group A 57 patients (50.9%) had eGFR <60ml/min/1.73m2, 55 patients (49.1%) had eGFR ≥60ml/min. The difference in estimated GFR was found statistically significant (P<0.001). Left ventricular ejection fraction <40% was present in 6 (5.4%), 7 (5.1%) in group A and B respectively, ≥40% in 106 (94.6%), 131 (94.9%) in group A and B respectively, were found non-significant (Table 4) . Pre-and post-procedure serum creatinine concentration and estimated GFR in the two study groups. Both pre-procedure (107.57±25.48 and 87.01±12.88 µmol/L) and post-procedure (123.23±35.81 and 95.71±1493 µmol/L) mean (±SD) serum creatinine concentration was significantly higher (P<0.001) in group A patients compared to group B patients. In both group A and group B, post-procedure serum creatinine concentration was significantly higher (P<0.001) compared to pre-procedure. Similarly, both pre-procedure (66.74±19.74 and 84.52±14.44 ml/min/1.73 m2) and post-procedure (57.63±14.18 and 76.18±13.46 ml/min/1.73 m2) mean (±SD) estimated GFR was significantly higher (P<0.001) in group B patients compared to group A patients. In both group A and group B, post-procedure estimated GFR was significantly lower (P<0.001) compared to pre-procedure (Table 5) . Table 3 : Distribution of study subject on the basis of procedure followed in this study Statistical analysis done by Chi by Chi-square test; Ns = Not significant; *** = Significant at P<0.001
Risk Factors
The mean (±SD) peak increase in serum creatinine concentration at 48-hour post-procedure from pre-procedure values. The mean (±SD) peak increase in group A compared to group B was significantly higher (P<0.001) (15.66±15.44 and 8.69±9.81µmol/L) ( Table  6 
Discussion
This study demonstrates that CIN is a frequent complication after coronary angiogram and percutaneous coronary intervention and the incidence of CIN is higher especially in patient with selected risk factors in diabetes patients. In present study showed the mean age of the study patients in group A was 55.83±9.00 years, where as in group B it was 50.44±11.63 years. Highest number of patients (33.5%) was in the age group of 50-60 years. The mean age difference between two groups were found statistically significant (p<0.05). A total of 206 patients were male (82.4%) and remaining 44 patients (17.6%) were female, male to female ratio was 4.68:1 In study of Mishima et al6 observed that the mean values for age was found 62.3±12.2 years. Alrawahi et al 7 study showed 98(45.6%) patients were male in case and 121(33.8%) in control group. Presents study showed the mean body mass index (BMI) of the studied subjects were 23.74±2.82 and 23.17±2.19 kg/m 2 in group A and group B respectively, the mean body mass index were similar in two groups. Mishima et al 6 study observed the mean BMI was found 26.1±5.5 kg/m 2 . Present study revealed that the mean systolic blood pressure was 127.45±14.43 mmHg and 126.01±11.87 mmHg in group A and B respectively. Diastolic blood pressure was 63.13±9.35 mmHg in group A and B respectively. Systolic and diastolic blood pressure between two groups was found statistically not significant. The mean baseline serum creatinine was 107.57±25.48 µmol/L and 87.01±12.88 µmol/L in group A and B respectively. This difference was statistically significant (p<0.001). Sharma et al8 study showed the incidence of CIN in patients with preexisting impairment of renal function (baseline creatinine clearance <60 ml/min) was 45.45% vs. 4.04% in patients with baseline creatinine clearance ≥60 ml/min (p<0.001). There was no difference regarding the amount of contrast agent administered between patients with different baseline creatinine clearance. Rihal et al 4 found a low risk (2.4%) of CIN in patients with normal renal function, but a high risk (30.6%) in those with serum creatinine levels ≥3.0 mg/dL. The mean volume of contrast media administered was 81.03±36.53 ml and 59.41±20.89 ml in group A and B respectively, difference was statistically significant (p<0.001). Chao et al 9 study observed the volume of administered contrast medium can be another important factor regarding the risk of contrast-induced AKI. Multiple studies have identified that the mean contrast volume is an independent predictor of CIN [10] [11] . Circumstantial evidence has pointed out that intra-arterial injection of contrast medium carries a higher risk of contrast-induced AKI than intravenous use 11 . However, no mechanisms have been provided to explain this phenomenon 12 . In different studies throughout the world shown number of risk factors for the development of CIN. Out of those pre existing impairment of renal function (eGFR < 60 ml/min/1.73m 2 BSA), diabetes mellitus, dyslipidemia and myocardial were identified as significant risk factors. Kim et al 13 report left ventricular ejection fraction less than 40%, GFR less than 60 ml/min/1.73 m 2 , serum reactive protein C more than 0.5 mg/dl and contrast volume consumption more than 250 cc as CIN's independent risk factors. Basal Scr level, shock, female gender, DM were CIN's risk factors in report of Ghani et al 14 .
Renal underlying disease, hemodynamic instability, dyslipidemia, hypotension after angiography were risk factors for CIN in Valente et al 15 research. In our study selected common risk factor reveled hypertension (42.0%) was the commonest followed by diabetes mellitus (34.4%), impaired renal function (22.8%). Among male and female distribution of risk factors were not significant. One hundred one (90.2%) patients had base line serum creatinine ≤140 µmol/L in group A and 138 (100%) in group B. Fifty seven (50.9%) patients had estimated GFR (<60 ml/min/1.73m 2 body surface Area) in group A and none in group B. The difference were statistically significant (p<0.001). Six (5.4%) patients had low LVEF (<40%) in group A and 7(5.1%) in group. LVEF was not statistically significant (p=0.920). Assareh et al16 study observed CIN occurs in 4(2.2%) patients with GFR measured by 24- 26 found that despite of giving pre procedure hydration CIN occur in 1/3 patient who underwent PCI and serum creatinine ≥1.8 mg/dL, another study by same group in 2000 found that 37.0% patients developed CIN rise of serum creatinine ≥25% who had impaired renal function. Those incidence is almost consistent with our study, 33.3% incidence in patients with preexisting impaired renal function. In our study we detect diabetes mellitus as a statistically significant risk factor. 16 29 showed that incidence of CIN was 10% for nonazotemic patient vs 30.0% for azotemic patient, 16.0% for diabetic non azotemic patients as 38% for patients who were both diabetic and azotemic.
Conclusion
CIN was significant developed in diabetes group than non-diabetes. Left ventricular ejection fraction and total volume of contrast media used was significantly higher in diabetes group than non diabetes group B patients.
